Skip to content
Global CDMO partner, since 2005

Your globalCDMOpartner.

Manufacturing trust for 200+ pharma companies across 80+ countries. From concept and formulation to globally accredited, regulated-market supply.

Enquire Explore capabilities
Brand filmConcept · Scale · Supply
80+
Countries shipped
200+
Pharma partners
1000+
Formulations
30+
Accreditations
Partners

The companies that trust us with their products.

A manufacturing partner to global majors and India's largest pharma houses — across regulated markets, dosage forms and brand families.

Sun Pharma
GSK
Cipla
Pfizer
Torrent Pharma
Novartis
Lupin
Bayer
Mankind Pharma
Teva
Biocon
Abbott
Zydus Lifesciences
Sanofi
Dr. Reddy's Laboratories
AstraZeneca
Glenmark
Merck (MSD)
Alkem Laboratories
Eli Lilly
Aurobindo Pharma
Global majorsTop Indian pharmaBrand owners & distributors
See full partner list
Scale & reach

Two decades of measurable manufacturing trust.

A vertically integrated CDMO delivering across dosage forms, geographies and regulatory regimes since 2005.

01Products1000+Developed and manufactured across regulated markets.
02Countries80+Supplied across six continents.
03Partners200+Pharma companies, brand owners and distributors.
04Accreditations30+WHO-GMP, PIC/S, ISO, Health Canada, AYUSH and more.
05Manufacturing10Manufacturing units across two factories in Himachal Pradesh.
06People1200+Employees, scientists and specialists.
What we make

Five verticals. One quality system.

A single quality regime across every dosage form we manufacture, from oral solids to sterile injectables.

01 · Flagship vertical

Pharmaceuticals

Our oldest and largest vertical. Tablets, capsules, syrups, suspensions and ointments — produced across sixteen lines and two factories under a single, audited quality regime built for regulated-market supply.

5M
Nasal spray units / year
3BN
Tablets / year
650M
Capsules / year
02

Injectables

Grade A/B sterile fill-finish across vials, ampoules and pre-filled syringes — built to the regulatory bar of our most demanding markets.

03

Derma & Cosmetics

Hypoallergenic serums, topical creams and dermatologist-tested formulations for skincare and personal-care brands.

04VITAGEN

Nutraceuticals

Daily-wellness softgels, gummies, sachets and effervescents — including our own consumer brand, VITAGEN.

05AYUSH

Herbal

Standardised herbal extracts and traditional formulations — AYUSH-certified and contract-manufactured for global wellness brands.

Flagship capability

Pioneer in nasal sprays.

Among India's earliest manufacturers to industrialise metered nasal-spray and DPI production. Aqueous, suspension and powder platforms, validated for global filings, exported to 40+ countries.

  • Trusted to manufacture Allegra Nasal for Sanofi.

  • 10+ innovative formulations under development, first time in India.

  • USFDA-compliance nasal plant coming online by 2028.

See the technology Discuss a project
Metered nasal sprayBiodeal metered nasal spray product
Capabilities

A full-service partner, built with a manufacturer's precision.

Four engagement models, one quality system, engineered for pharma companies that need scale without compromise.

01

Contract Manufacturing

End-to-end CDMO across solids, liquids, semi-solids and sterile dosage forms. 200+ partners.

02

Loan Licensing

P2P arrangements under partner brand and registrations. 60+ active licensees.

03

Research & Development

DSIR-approved labs. 14 F&D resources, 11 scientists. Formulation, analytical, regulatory.

04

Nasal & DPI Systems

Dedicated platform. Aqueous, suspension and powder lines. 14 patents.

Manufacturing footprint

Two factories. Ten manufacturing units.

Eco-friendly, pollution-free belt. WHO-GMP and PIC/S certified. Built for scale and for the regulators of tomorrow's markets.

Geographic footprint, North India

Two manufacturing factories in Himachal Pradesh, supported by the corporate office in Noida. A third facility for nasal, nutra and herbal lines is under build-out.

Manufacturing
Upcoming
Corporate
Linked
N0  100 KMUNIT INALAGARHUNIT IIPAONTA SAHIBNASAL PLANTUPCOMINGNOIDACORPORATE31.0°N · 77.1°E
Unit I · Nalagarh, HP

Where 3 billion tablets are made each year.

Seven manufacturing blocks on a 5.5-acre site. WHO-GMP and PIC/S certified. Specialised laser-coding line under PLC control. Full 24/7×4 surveillance on packaging.

Tablets / yr
3 Bn
Capsules / yr
650 M
Tubes / yr
21 M
Site
5.5 ac
Unit II · Paonta Sahib, HP

Sterile core. Grade A and B.

Three manufacturing blocks on 14 acres. Twelve injectable lines under dedicated WFI and pure-steam utilities.

Site
14 ac
Built-up
57,661 m²
Inj. lines
12
Grade
A / B
In development

USFDA nasal plant and nutra & herbal facility.

Built ground-up for US-market submissions, with EU-GMP accreditation pipeline alongside. Coming online by 2028.

Online by
2028
Compliance
USFDA
Pipeline
EU-GMP
Market
US + EU
1,200+ people, 80+ countries served.
See full manufacturing capabilities
Credentials

A wall of credentials, a single open file.

39 accreditations across pharma, quality, lab, food and trade — every one a real audit on a real schedule.

Story

20+ years of disciplined manufacturing habit.

Since 2005

Biodeal began in 2005 with one tablet line in Nalagarh, a small team, and an unfashionable belief that quality is a habit, not a department. Twenty years on, that habit has shipped to eighty countries, kept faith with two hundred partners, and built one of India's most respected contract manufacturing organisations.

Milestones2005 to 2026
  • 2005Incorporated, Unit I Nalagarh
  • 2008WHO-GMP certified
  • 2011Nasal-spray platform commissioned
  • 2017Unit II Paonta Sahib, sterile lines
  • 2024Health Canada audit cleared
  • 2025Piramal strategic financing
  • 2026Injectable CDMO capability established; 12-line Grade A/B sterile facility acquired
Investor preview

Building India's next-generation pharmaceutical CDMO.

Backed by Piramal Alternatives' strategic investment, Biodeal is scaling capacity and export reach for the next phase of growth.

Investor relations
40–45%
Annual growth · 5-yr CAGR
12
Grade A/B sterile lines
Piramal
2025 strategic deal
On the record

Momentum, on the record.

Filings, certifications and recognition from the last twelve months.

FinanceNov 2024

Piramal Group enters strategic financing partnership with Biodeal.

A multi-year facility that accelerates capacity expansion for the company's next phase of growth.

Read article
RegulatoryApr 2024

Health Canada accreditation extends nasal export reach.

Site-licensing opens regulated-market supply for nasal spray and DPI product lines.

Read article
RecognitionFeb 2024

Industry award for excellence in contract manufacturing.

Recognised among India's leading CDMOs for quality systems and export performance.

Read article
Enquire

Tell us what you need to make.

A focused brief gets you a routed answer from the right team within one working day.